Lessons learned from COVID-19 on potentially pathogenic soil microorganisms

Haifeng Qian; Qi Zhang; Tao Lu; Willie J.G.M. Peijnenburg; Josep Penuelas; Yong‐Guan Zhu

doi:10.1007/s42832-020-0068-9

Article2023

Therapeutic strategies for COVID-19: progress and lessons learned

Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, De Clercq Erik

Article2024

Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic

Niloufar Yazdanpanah, Constantine Sedikides, Hans D. Ochs, Carlos A. Camargo, Gary L. Darmstadt, Artemi Cerdà, Valentina Cauda, Godefridus J. Peters, Frank W. Sellke, Nathan D. Wong, Elisabetta Comini, A. Ruiz-Jimeno, Vivette Glover, Nikos Hatziargyriou, Christian E. Vincenot, Stéphane Bordas, Idupulapati M. Rao, Hassan Abolhassani, Gevork B. Gharehpetian, Ralf Weiskirchen, Manoj Gupta, Shyam Singh Chandel, Bolajoko O. Olusanya, Bruce D. Cheson, Alessio Pomponio, Michael Tänzer, Paul S. Myles, Wen‐Xiu Ma, Federico Bella, Saeid Ghavami, S. Moein Moghimi, Domenico Praticò, Alfredo Martínez Hernandez, María Martínez‐Urbistondo, Diego Martínez‐Urbistondo, Seyed‐Mohammad Fereshtehnejad, Imran Ali, Shinya Kimura, A. Wallace Hayes, Wenju Cai, K.J. Chua, Sabu Thomas, Kazem Rahimi, Armin Sorooshian, Michael Schreiber, Koichi Kato, John H. T. Luong, Stefano Pluchino, Andrés M. Lozano, John F. Seymour, Kenneth S. Kosik, Stefan G. Hofmann, Roger S. McIntyre, Matjaž Perc, Alexander Leemans, Robyn S. Klein, Shuji Ogino, Christopher Wlezien, George Perry, Juan J. Nieto, Lisa A. Levin, Daniel J. Klionsky, Bahram Mobasher, T. Dorigo, Nima Rezaei

Article2021

Lessons learned from COVID-19 on potentially pathogenic soil microorganisms

Discussion(0)

Related publications

Therapeutic strategies for COVID-19: progress and lessons learned

Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic

Lessons Learned from COVID-19 Trials – Should We Be Doing Clinical Trials Differently?

Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?

Lessons from Trans-Domain Assessment of COVID 19 Outbreak